A drug trial of patients with rectal cancer just experienced something of a scientific miracle: after six months of experimental treatment, their tumors disappeared.
A tiny group of people with rectal cancer just experienced something of a scientific miracle: their cancer simply vanished after an experimental treatment.
In a very small trial done by doctors at New York's Memorial Sloan Kettering Cancer Center, patients took a drug called dostarlimab for six months. The trial resulted in every single one of their tumors disappearing. The trial group included just 18 people, and there's still more to be learned about how the treatment worked. But some scientists say these kinds of results have never been seen in the history of cancer research.
Dr. Hanna Sanoff of the University of North Carolina's Lineberger Comprehensive Cancer Center joined NPR'sto outline how this drug works and what it could mean for the future of cancer research. Although she was not involved with the study, Dr. Sanoff has written about the results.I mean, I am incredibly optimistic. Like you said in the introduction, we have never seen anything work in 100 percent of people in cancer medicine.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Every patient in this experimental drug trial saw their cancer disappear, researchers sayA small clinical trial found that every single rectal cancer patient who received an experimental immunotherapy treatment had their cancer go into remission.
Leer más »
Weather Didn't Stop Cyclists From Participating In American Cancer Society's 50th Annual Bike-A-Thon Bridge To The BeachIt was a big day for the American Cancer Society. Thousands of cyclists pedaled their way to Atlantic City for the 50th annual Bike-A-Thon Bridge To The Beach on Sunday. NewsWakisha reports.
Leer más »
How Coloradans are trying to thwart antibiotic-resistant bacteria: “It’s a silent pandemic”Efforts to create new antibiotics face significant hurdles: a Colorado senator’s bill to give drug companies incentives has stalled, and a different type of treatment being researched in Boul…
Leer más »
My work digging up the shelters of our ancestorsLudovic Slimak, a cultural anthropologist at the CNRS and the University of Toulouse — Jean Jaurès, describes his research and the changing face of archaeology in France.
Leer más »
My work digging up the shelters of our ancestorsLudovic Slimak, a cultural anthropologist at the CNRS and the University of Toulouse — Jean Jaurès, describes his research and the changing face of archaeology in France.
Leer más »
The Billionaire Funding a Battle Against Hospital MonopoliesA legal campaign to force changes at giant healthcare systems has new backing from John Arnold, a philanthropist who confronted pharmaceutical giants over drug prices.
Leer más »